Interest of a metabolic anti-ischemic agent in the management of coronary diabetic patients, throwback to the Cardiology Masterclass 2020 with Dr Veronica de Chavez
Doctor Veronica de Chavez, cardiologist and founder of the cardiometabolic center in San Salvador, shares with us the high prevalence of patients with coronary disease and diabetes mellitus and the higher risk of heart attacks of these patients. She also explains how Trimetazidine is particularly adapted to this specific sub-group of patients
Keep up to date with our content
Subscribe to our newsletter so that you are always up to date with the news.